TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8770627

Group type: EXPERIMENTAL
Intervention: Slightly suppressive L-thyroxine doses (50-200 micrograms/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (matched for age, sex, body mass index, menopausal and thyroid disease)
Number of subjects: 50
Study: 1963191

Group type: EXPERIMENTAL
Intervention: Active antihypertensive treatment
Number of subjects: 742

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 742
Study: 6117459

Group type: EXPERIMENTAL
Intervention: 5 mg clotiazepam
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 5 mg diazepam
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 31600034

Group type: EXPERIMENTAL
Intervention: Oral nonsteroidal antiinflammatory therapy
Number of subjects: 449
Study: 29198844

Group type: EXPERIMENTAL
Intervention: Facts Up Front
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: binary symbol
Number of subjects: 161

Group type: COMPARATOR
Intervention: no-label control
Number of subjects: 161
Study: 26689171

Group type: EXPERIMENTAL
Intervention: Mobile texting aftercare intervention
Number of subjects: 80

Group type: COMPARATOR
Intervention: Aftercare-as-usual control group
Number of subjects: 80
Study: 25299584

Group type: EXPERIMENTAL
Intervention: NPM1 type A mutations
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Rare type NPM1 mutations
Number of subjects: 349

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 349
Study: 22299715

Group type: EXPERIMENTAL
Intervention: Bismuthyl ecabet 400 mg single dose
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Bismuthyl ecabet 800 mg single dose
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Bismuthyl ecabet 1200 mg single dose
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Bismuthyl ecabet 200 mg single dose
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Bismuthyl ecabet 1600 mg single dose
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Bismuthyl ecabet 1200 mg twice daily (multiple dose)
Number of subjects: 77
Study: 20218755

Group type: EXPERIMENTAL
Intervention: Recruitment procedures
Number of subjects: 280

Group type: COMPARATOR
Intervention: Chi-square and t tests
Number of subjects: 280
Study: 17489900

Group type: EXPERIMENTAL
Intervention: Presence of ob/gyn direct access laws
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alternate specifications explored
Number of subjects: 0
Study: 15771277

Group type: EXPERIMENTAL
Intervention: PPG probe measurements
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PPG probe measurements for anterior tibial artery
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PPG probe measurements for posterior tibial artery
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PPG probe measurements from dorsalis pedis artery in intensive care patients
Number of subjects: 30
Study: 11994358

Group type: EXPERIMENTAL
Intervention: 800 microg ciclesonide in the morning
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 800 microg ciclesonide in the evening
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 400 microg ciclesonide inhaled twice daily
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 9667257

Group type: EXPERIMENTAL
Intervention: Prognostic Index (constructed using ADJCT, DLNs, HEP, LDH, DFI)
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Prognostic Index (validated in another cohort of 315 patients)
Number of subjects: 233
Study: 7859696

Group type: EXPERIMENTAL
Intervention: Hologic DXA
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Lunar DXA
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Norland DXA
Number of subjects: 11

Group type: COMPARATOR
Intervention: Underwater Weighing (UWW)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Bioelectric Impedance Analysis (BIA) instruments
Number of subjects: 11
Study: 2687193

Group type: EXPERIMENTAL
Intervention: Ioversol
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sodium/meglumine diatrizoate
Number of subjects: 80
Study: 30449328

Group type: EXPERIMENTAL
Intervention: Memantine (10 mg bid)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 26994010

Group type: EXPERIMENTAL
Intervention: Splenic irradiation
Number of subjects: 225

Group type: COMPARATOR
Intervention: No splenic irradiation (Control)
Number of subjects: 225
Study: 24782726

Group type: EXPERIMENTAL
Intervention: Sleep group (n=17)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Sleep group (n=17) with nocturnal waking <60 min
Number of subjects: 35

Group type: COMPARATOR
Intervention: Wake group (n=18)
Number of subjects: 35
Study: 22716774

Group type: EXPERIMENTAL
Intervention: Contingent behavioral incentives (CBI: n = 42)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Non-contingent behavioral incentives (NCBI: n = 28)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Treatment as usual (TAU: n = 32)
Number of subjects: 102
Study: 20015129

Group type: EXPERIMENTAL
Intervention: DDD pacing
Number of subjects: 30

Group type: COMPARATOR
Intervention: VVIR pacing
Number of subjects: 30
Study: 17639095

Group type: EXPERIMENTAL
Intervention: BNP infusion
Number of subjects: 28
Study: 12015790

Group type: EXPERIMENTAL
Intervention: MDI
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: MDI+SP
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: DPI
Number of subjects: 3

Group type: COMPARATOR
Intervention: MDI+SP vs. MDI
Number of subjects: 3

Group type: COMPARATOR
Intervention: DPI vs. MDI
Number of subjects: 3

Group type: COMPARATOR
Intervention: MDI+SP vs. DPI
Number of subjects: 3
Study: 9404175

Group type: EXPERIMENTAL
Intervention: Nalbuphine (0.3 mg.kg‐1)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Buprenorphine (2.5 micrograms.kg‐1)
Number of subjects: 60
Study: 1821970

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 23

Group type: COMPARATOR
Intervention: Imipramine and Amitriptyline
Number of subjects: 23
Study: 7032332

Group type: EXPERIMENTAL
Intervention: Perioperative cefamandole
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 30084152

Group type: EXPERIMENTAL
Intervention: Moisturizing gel containing a pseudo‐ceramide and a eucalyptus extract, applied twice a day for 4 weeks.
Number of subjects: 44

Group type: COMPARATOR
Intervention: No moisturizer (control group).
Number of subjects: 44
Study: 29053121

Group type: EXPERIMENTAL
Intervention: Cavinton R for drop infusions (10 intravenously during 10 days) followed by cavinton R comforte in dose 10 mg, 1 tablet 3 times a day during 90 days
Number of subjects: 164

Group type: COMPARATOR
Intervention: Basic therapy only
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Cavinton R for drop infusions and cavinton R comforte
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Cavinton R and cavinton R comforte
Number of subjects: 164
Study: 25569495

Group type: EXPERIMENTAL
Intervention: Isolite illuminated isolation system
Number of subjects: 50

Group type: COMPARATOR
Intervention: Saliva ejector
Number of subjects: 50
Study: 24508473

Group type: EXPERIMENTAL
Intervention: AZD7009
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 21958025

Group type: EXPERIMENTAL
Intervention: 2 μg·kg(‐1) fentanyl (group F, n = 40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: 2 mg·kg(‐1) tramadol (group T, n = 40)
Number of subjects: 80
Study: 19280974

Group type: EXPERIMENTAL
Intervention: Finishing Gloss
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Protect‐It
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: LC Varnish
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Adper Single Bond
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Nail Varnish
Number of subjects: 378

Group type: COMPARATOR
Intervention: Positive Control (unprotected)
Number of subjects: 378

Group type: COMPARATOR
Intervention: Negative Control (unprotected)
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Experimental groups (protected)
Number of subjects: 378
Study: 17883853

Group type: EXPERIMENTAL
Intervention: Multidisciplinary outpatient care program consisting of a workplace intervention based on participatory ergonomics and a graded activity program using cognitive behavioural principles.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care provided by the medical specialist, occupational physician, general practitioner, and allied health professionals.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multidisciplinary outpatient care program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 15355144

Group type: EXPERIMENTAL
Intervention: Visual short-term memory task with visual interference
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spatial memory task with spatial interference
Number of subjects: 0

Group type: COMPARATOR
Intervention: Visual short-term memory task with spatial interference
Number of subjects: 0

Group type: COMPARATOR
Intervention: Spatial memory task with visual interference
Number of subjects: 0
Study: 11442522

Group type: EXPERIMENTAL
Intervention: Polypropylene mesh
Number of subjects: 100

Group type: COMPARATOR
Intervention: Nylon darn
Number of subjects: 100
Study: 9679573

Group type: EXPERIMENTAL
Intervention: Extensive radical surgery (Japanese operation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: TME (Total Mesorectal Excision)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Function-preserving operations (e.g., EMR)
Number of subjects: 0
Study: 7585769

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Emergency medical system
Number of subjects: 0
Study: 1703598

Group type: EXPERIMENTAL
Intervention: 0.4 mg intravenous isradipine
Number of subjects: 10

Group type: COMPARATOR
Intervention: 2 mg intravenous nifedipine
Number of subjects: 10
Study: 762032

Group type: EXPERIMENTAL
Intervention: Oxazepam
Number of subjects: 65

Group type: COMPARATOR
Intervention: Chlordiazepoxide
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 29985679

Group type: EXPERIMENTAL
Intervention: Sodium Phosphate (SP) supplementation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 28680540

Group type: EXPERIMENTAL
Intervention: Somatic Experiencing (SE) in addition to treatment-as-usual (TAU)
Number of subjects: 91

Group type: COMPARATOR
Intervention: TAU alone
Number of subjects: 91
Study: 26444090

Group type: EXPERIMENTAL
Intervention: IPX066
Number of subjects: 560
Study: 22247720

Group type: EXPERIMENTAL
Intervention: EPA + vitamin C (500 mg EPA and 200 mg vitamin C)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: EPA + placebo (500 mg EPA and placebo vitamin C)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Placebo + vitamin C (placebo EPA and 200 mg vitamin C)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo + placebo (placebo EPA and placebo vitamin C)
Number of subjects: 65
Study: 19535716

Group type: EXPERIMENTAL
Intervention: Ropivacaine infiltration (20 mL of ropivacaine 0.75%)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Ropivacaine infiltration
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control (IV acetaminophen combined with nalbuphine)
Number of subjects: 52
Study: 17366241

Group type: EXPERIMENTAL
Intervention: Gender-based recovery model; 12 sessions in group format over two months
Number of subjects: 0
Study: 15009362

Group type: EXPERIMENTAL
Intervention: Periprostatic local anesthesia with 1% lidocaine
Number of subjects: 90

Group type: COMPARATOR
Intervention: Periprostatic saline injection
Number of subjects: 90

Group type: COMPARATOR
Intervention: No local anesthesia
Number of subjects: 90
Study: 11158416

Group type: EXPERIMENTAL
Intervention: Rapamycin-based immunosuppression (group 1)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Mycophenolate-based immunosuppression (group 2)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Healthy subjects (group 3)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Rapamycin-based immunosuppression (group 1A)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Rapamycin-based immunosuppression (group 1B)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: All groups at 28 weeks
Number of subjects: 38
Study: 9517769

Group type: EXPERIMENTAL
Intervention: Intravenous methotrexate (MTX) 0.3 mg/kg once weekly plus daily oral low dose prednisone
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Concomitant prednisone dose of 7.5 mg/day
Number of subjects: 17

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Weekly low dose MTX in combination with low dose corticosteroids
Number of subjects: 17
Study: 9869045

Group type: EXPERIMENTAL
Intervention: Anastomosis with one layer of suture (Gambee stitches)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Anastomosis with two layers of suture (first with Connel‐Mayo stitches then with Lembert)
Number of subjects: 86
Study: 2785545

Group type: EXPERIMENTAL
Intervention: Magaldrate (Riopan)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Aluminium hydroxide (Trigastril)
Number of subjects: 30
Study: 142502

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (no aerosol)
Number of subjects: 12
Study: 30831579

Group type: EXPERIMENTAL
Intervention: Growing Up Milk 'Lite' (GUMLi)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard cow milk
Number of subjects: 160

Group type: COMPARATOR
Intervention: Comparison of GUMLi and cow milk
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: GUMLi
Number of subjects: 160
Study: 27513822

Group type: EXPERIMENTAL
Intervention: Fluid-liberal strategy
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Fluid-conservative strategy
Number of subjects: 1000
Study: 26070589

Group type: EXPERIMENTAL
Intervention: Diet high in cereal fiber, free of red meat, and high in coffee (n = 13)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Diet low in fiber, high in red meat, and coffee free (n = 15)
Number of subjects: 28
Study: 23672928

Group type: EXPERIMENTAL
Intervention: Temsirolimus 25mg i.v. administered weekly in 4 week cycles
Number of subjects: 38
Study: 21692021

Group type: EXPERIMENTAL
Intervention: Bipolar radio-frequency ablation
Number of subjects: 187

Group type: COMPARATOR
Intervention: Microwave ablation
Number of subjects: 187
Study: 19573479

Group type: EXPERIMENTAL
Intervention: Iloperidone
Number of subjects: 409

Group type: COMPARATOR
Intervention: Ziprasidone
Number of subjects: 409
Study: 16406909

Group type: EXPERIMENTAL
Intervention: Preoperative behavioral training
Number of subjects: 125

Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 125
Study: 14729291

Group type: EXPERIMENTAL
Intervention: Structured presentation (illustrated chart explaining the process and possible outcomes of screening, followed by screeners checking understanding)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard presentation (leaflet and short verbal explanation of the test)
Number of subjects: 40
Study: 12526313

Group type: EXPERIMENTAL
Intervention: GM-CSF and alpha-INF joint treatment (experimental group)
Number of subjects: 36

Group type: COMPARATOR
Intervention: alpha-INF alone (control group)
Number of subjects: 36
Study: 9395275

Group type: EXPERIMENTAL
Intervention: Conjugated equine oestrogens (CEE) 0.625 mg
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Oestradiol valerate 1 mg
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Oestradiol implants 50 mg
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Oestradiol + medroxyprogesterone acetate (MPA) 2 mg + 5 mg
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Oestradiol + norethisterone acetate (NE) 2 mg + 1 mg
Number of subjects: 56
Study: 8195446

Group type: EXPERIMENTAL
Intervention: Electronic pressure‐controlled probing set at 25 g
Number of subjects: 100

Group type: COMPARATOR
Intervention: Hand probing (conventional method)
Number of subjects: 100
Study: 3273871

Group type: EXPERIMENTAL
Intervention: Stuartnatal 1 + 1
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Stuart Prenatal
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Materna
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Natalins Rx
Number of subjects: 36
Study: 31416637

Group type: EXPERIMENTAL
Intervention: StrataGraft tissue
Number of subjects: 30

Group type: COMPARATOR
Intervention: Autograft
Number of subjects: 30
Study: 28030444

Group type: EXPERIMENTAL
Intervention: Sugammadex (2.0 mg/kg)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Neostigmine (0.05 mg/kg)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Spontaneous recovery
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study: 26607841

Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 23877110

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided periradicular injections
Number of subjects: 40

Group type: COMPARATOR
Intervention: Computed tomography-controlled periradicular injections
Number of subjects: 40
Study: 21920865

Group type: EXPERIMENTAL
Intervention: Whiplash-associated disorders (WAD) patients
Number of subjects: 91

Group type: COMPARATOR
Intervention: Noninjured neck pain controls
Number of subjects: 91
Study: 19491335

Group type: EXPERIMENTAL
Intervention: MK-0657 7 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Carbidopa/levodopa 25/250 mg (LD)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 16490488

Group type: EXPERIMENTAL
Intervention: Bilateral LASIK with superior-hinge Hansatome microkeratome (n = 17)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Bilateral LASIK with nasal-hinge Amadeus microkeratome (n = 18)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Preoperative myopia
Number of subjects: 35

Group type: COMPARATOR
Intervention: Laser-calculated ablation depth
Number of subjects: 35

Group type: COMPARATOR
Intervention: Combined ablation depth and flap thickness
Number of subjects: 35
Study: 15573453

Group type: EXPERIMENTAL
Intervention: Lifestyle Modification
Number of subjects: 2934

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 2934

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2934
Study: 10758447

Group type: EXPERIMENTAL
Intervention: Granisetron 40 microg kg-1 plus dexamethasone 8 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Granisetron 40 microg kg-1
Number of subjects: 120
Study: 9438777

Group type: EXPERIMENTAL
Intervention: Irbesartan (AT1 angiotensin II receptor antagonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amlodipine (calcium channel blocker)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8395719

Group type: EXPERIMENTAL
Intervention: LU 47311 (reviparin)
Number of subjects: 41
Study: 3468891

Group type: EXPERIMENTAL
Intervention: Low-tar cigarettes (5 mg/cig.)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medium-tar cigarettes (15 mg/cig.)
Number of subjects: 0
Study: 31237947

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) 400 mg/d for 24 weeks
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ)
Number of subjects: 77
Study: 29391360

Group type: EXPERIMENTAL
Intervention: Gabapentin (up to 2700 mg)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 26897383

Group type: EXPERIMENTAL
Intervention: Fixed-dose glucagon stimulation test (FD-GST: 1 or 1.5 mg in patients >90 kg)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Weight-based glucagon stimulation test (WB-GST: 0.03 mg/kg)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Fixed-dose glucagon stimulation test (FD-GST)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Weight-based glucagon stimulation test (WB-GST)
Number of subjects: 28
Study: 24296325

Group type: EXPERIMENTAL
Intervention: HMM+SMC
Number of subjects: 0

Group type: COMPARATOR
Intervention: HMM
Number of subjects: 0
Study: 22790107

Group type: EXPERIMENTAL
Intervention: Preventive in-home comprehensive geriatric assessment (CGA) performed by trained medical students using the STEP-tool
Number of subjects: 1620

Group type: COMPARATOR
Intervention: Usual general practitioner care (Control)
Number of subjects: 1620
Study: 20003095

Group type: EXPERIMENTAL
Intervention: Alverine citrate 60 mg with simeticone 300 mg three times daily for 4 weeks
Number of subjects: 412

Group type: COMPARATOR
Intervention: Matching placebo for 4 weeks
Number of subjects: 412
Study: 17706655

Group type: EXPERIMENTAL
Intervention: Small hand paddles (116 cm²)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Large hand paddles (268 cm²)
Number of subjects: 8

Group type: COMPARATOR
Intervention: No paddles (control)
Number of subjects: 8
Study: 16228857

Group type: EXPERIMENTAL
Intervention: Flexible-tip laparoscopes (Olympus LTF-V3 and Fujinon EL2-TF310)
Number of subjects: 29

Group type: COMPARATOR
Intervention: 30 degrees lens rigid laparoscope
Number of subjects: 29

Group type: COMPARATOR
Intervention: 0 degrees lens rigid laparoscope
Number of subjects: 29
Study: 12744893

Group type: EXPERIMENTAL
Intervention: Men C-CRM(197) conjugate vaccine
Number of subjects: 193
Study: 10232438

Group type: EXPERIMENTAL
Intervention: Bronchoscopy and bronchoalveolar lavage (BAL) in skiers
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Bronchoalveolar lavage (BAL) fluid analysis in skiers
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Detection of inflammatory markers in skiers
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Comparison of inflammatory index in skiers with ski asthma
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lymphocyte subtypes and activation markers in skiers
Number of subjects: 40

Group type: COMPARATOR
Intervention: Concentration of albumin, fibronectin, and hyaluronan in skiers
Number of subjects: 40
Study: 8734400

Group type: EXPERIMENTAL
Intervention: Occlusion of vision via opaque goggles
Number of subjects: 2

Group type: COMPARATOR
Intervention: No visual occlusion
Number of subjects: 2